Clinical trial
Enzastaurin to Treat Recurrent Brain Tumor
NCT00108056 · National Cancer Institute (NCI), NIH · Terminated
Key facts
| NCT number | NCT00108056 |
|---|---|
| Title | Enzastaurin to Treat Recurrent Brain Tumor |
| Official title | A Phase I Trial of Enzastaurin (LY317615) in Patients With Recurrent Gliomas |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Glioma |
| Intervention type | Drug |
| Interventions | Enzastaurin (LY317615) monohydronchloride |
| Enrollment | 26 |
| Start date | Apr 7, 2005 |
| Primary completion | Apr 1, 2014 |
| Completion | Apr 1, 2014 |
| First posted | Apr 13, 2005 |
| Last update posted | Dec 5, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: